Surgery Partners Inc. (NASDAQ:SGRY) fell 0.3% during mid-day trading on Friday . The stock traded as low as $17.16 and last traded at $17.84, with a volume of 84,398 shares traded. The stock had previously closed at $17.89.

Several research analysts have weighed in on SGRY shares. Citigroup Inc. lowered their target price on shares of Surgery Partners from $25.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, March 14th. Royal Bank Of Canada lowered their target price on shares of Surgery Partners from $22.00 to $20.00 and set an “outperform” rating for the company in a research note on Monday, March 14th. Goldman Sachs Group Inc. lowered their target price on shares of Surgery Partners from $23.00 to $20.00 in a research note on Monday, March 14th. Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Thursday, April 21st. Finally, KeyCorp started coverage on shares of Surgery Partners in a research note on Thursday, June 9th. They set an “overweight” rating and a $21.00 target price for the company. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $22.75.

The company’s 50-day moving average is $15.63 and its 200-day moving average is $15.54. The firm has a market capitalization of $868.10 million and a price-to-earnings ratio of 716.00.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Thursday, May 5th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.03 by $0.18. The company had revenue of $267.10 million for the quarter, compared to analyst estimates of $255.06 million. The business’s revenue for the quarter was up 19.2% compared to the same quarter last year. On average, equities research analysts expect that Surgery Partners Inc. will post $0.54 EPS for the current year.

A number of hedge funds and institutional investors have recently made changes to their positions in SGRY. Oxford Asset Management purchased a new position in shares of Surgery Partners during the fourth quarter valued at $3,178,000. Sei Investments Co. purchased a new position in shares of Surgery Partners during the fourth quarter valued at $3,201,000. Wells Fargo & Company MN purchased a new position in shares of Surgery Partners during the fourth quarter valued at $14,025,000. Finally, Jennison Associates LLC purchased a new position in shares of Surgery Partners during the fourth quarter valued at $34,117,000.

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.